Getting an unexpected agency response that may have little to do with how Cialis is meant to be used, ICOS Corp. and Eli Lilly and Co. said the FDA issued an approvable letter for their erectile dysfunction product in which it requested three issues be resolved, one being pharmacology studies. (BioWorld Today)